StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)

Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –

Lantheus price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lantheus's price to book ratio was 5.1× on Nov 11, 2026, against 3.8× a year earlier. Over the last 5 years it ranged from 3.2× to 13.5×, with a median of 6.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.1×+0.8
2025Dec 31, 20254.3×−1.1
2024Dec 31, 20245.4×−0.8
2023Dec 29, 20236.2×+0.7
2022Dec 30, 20225.5×+1.6
2021Dec 31, 20213.9×+2.2
2020Dec 31, 20201.8×−6.2
2019Dec 31, 20198.0×−2.9
2018Dec 31, 201810.8×–

More Lantheus figures

See a number that looks wrong?